BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200204T110000
DTEND;TZID=America/New_York:20200204T123000
DTSTAMP:20260404T072143
CREATED:20200127T162038Z
LAST-MODIFIED:20200127T162038Z
UID:3752-1580814000-1580819400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - Non-traditional antibacterial therapeutic options and challenges
DESCRIPTION:In this webinar\, the following aspects will be presented: \n\nDiscovery and early development of “non-traditional” antibacterial approaches is a noticeable trend in the pre-clinical global pipeline\nThese approaches include anti-virulence strategies\, microbiome-modifying therapies\, phages and others such as nanoparticles\, immunotherapy and drug-resistance modulation\nSome of these approaches require novel preclinical efficacy models to predict clinical outcome\nPathogen-specific or even patient-specific strategies dominate this field\nA major challenge will be to show efficacy in clinical trials\n\nThe presentation will be followed by a Q&A session with Ursula Theuretzbacher and Laura Piddock (GARDP). \nSpeaker: Ursula Theuretzbacher\, CEFAIA\, Austria \nModerator: Prabhavathi Fernandes\, Chair of GARDP’s Scientific Advisory Committee \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-non-traditional-antibacterial-therapeutic-options-and-challenges/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200227T110000
DTEND;TZID=America/New_York:20200227T123000
DTSTAMP:20260404T072143
CREATED:20200127T163753Z
LAST-MODIFIED:20200127T163906Z
UID:3761-1582801200-1582806600@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - PK/PD murine infection models: Focus on study elements\, variability\, and interpretation of results
DESCRIPTION:In this webinar\, Alexander J. Lepak will review critical study elements that lead to robust preclinical PK/PD results in the murine model. \nTopics discussed will include: \n\nUnderstanding and embracing the inherent variability in many components of the murine model\nDemonstrating how to generate and interpret preclinical murine model PK/PD results\n\nThe presentation will be followed by a Q&A session. \nThe material presented in this webinar was shown but not recorded at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance 2019. \nSpeaker: Alexander J. Lepak\, Assistant Professor\, Department of Medicine\, University of Wisconsin School of Medicine and Public Health (USA) \nModerator: Peter Warn\, Evotec (UK) \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-pk-pd-murine-infection-models-focus-on-study-elements-variability-and-interpretation-of-results/
LOCATION:Webinar\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR